Acute kidney injury (AKI), associated with significant morbidity and mortality, is widely known to involve epithelial apoptosis, excessive inflammation, and fibrosis in response to ischemia or reperfusion injury, which results in either chronic pathological changes or death. Therefore, it is imperative that investigations are conducted in order to fi nd effective, early diagnoses, and therapeutic targets needed to help prevent and treat AKI. However, the mechanisms modulating the pathogenesis of AKI still remain largely undetermined. MicroRNAs (miRNAs), small noncoding RNA molecules, play an important role in several fundamental biological and pathological processes by a post transcriptional regulatory function of gene expression. MicroRNA-21 (miR-21) is a recently identifi ed, typical miRNA that is functional as a regulator known to be involved in apoptosis as well as inflammatory and fi brotic signaling pathways in AKI. As a result, miR-21 is now considered a novel biomarker when diagnosing and treating AKI. This article reviews the correlative literature and research progress regarding the roles of miR-21 in AKI.
INTRODUCTION
Acute kidney injury (AKI) is a common and serious disease that is costly to treat and often results in death. The incidence of AKI is on the rise in both high-income and low-income countries. Nearly 600,000 cases of AKI are reported each year in the United States (Rifkin et al., 2012) . However, the numbers are more severe in China with AKI affecting approximately one in a thousand individuals per year. Although insight into the causes and mechanisms of AKI is currently increasing, few early diagnostic and therapeutic options exist, which limits the timeframe of recovery to within only a few weeks of occurrence. In recent decades, compelling evidence has illuminated the pathological changes in AKI to include apoptosis, extensive inflammation, fibrosis, and ischemia reperfusion injury (IRI), which induce the expression of many transcriptional regulators and the activation of several signaling pathways.
MicroRNAs (miRNAs) are a class of small noncoding RNA molecules that regulate gene expression by functioning as a post-transcriptional regulatory factor. Consequently, nearly every biological process is estimated to be under the control of miRNAs. It has been recently demonstrated that miRNAs are essential regulators of a number of signaling cascades involved in the pathogenesis of renal disease in vivo and in vitro. Likewise, it has been confi rmed that dysfunctional miRNA expression, more specifi cally the expression of microRNA-21 (miR-21), has played a role in the up-regulation of mechanisms responsible for the progression of AKI. Therefore, using miRNAs as biomarkers as well as other targeted therapeutic strategies could provide early diagnosis and more effi cient treatment of AKI. In this review, we summarize our current knowledge about the role of miR-21 and its mechanism that is potentially associated with AKI pathogenesis.
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& a result of AKI, the natural cellular response is programmed death through both necrotic and apoptotic mechanisms (Humphreys et al., 2008) . Apoptosis is carried out through both an intrinsic pathway and an extrinsic pathway that ultimately result in the activation of effector apoptotic-specifi c proteases, which cleave structural proteins, signal transducers, regulators of transcription, repair factors, and many other targets within the cell (Buscaglia and Li, 2011) . However, the onset of AKI does not always lead to cell death, rather it is dependently associated with TECs that survive from the insult. Surviving TECs then dedifferentiate and proliferate to reconstitute a functioning nephron . MiR-21 has been reported to promote such proliferation and act as a strong anti-apoptotic factor to inhibit cell death (Chan et al., 2005; Cheng et al., 2010; Godwin et al., 2010) . Recent fi ndings have also shown that up-regulation of miR-21 contributed to a reduction in renal cell apoptosis and it also consistently shows protective effects against renal IRI after ischemic preconditioning (IPC) (Xu et al., 2012) .
Programmed cell death 4 (PDCD4) was among the earliest confirmed miR-21 targets in RCC, which therefore indicates that miR-21 is associated with growth, apoptosis, and cell cycle progression (Lv et al., 2013) . Furthermore, miR-21 overexpression was found to down-regulate promoter activity of PDCD4 by directly targeting the 3′UTR (Lu et al., 2008) . While knockdown of miR-21 induced signifi cant up-regulation of PDCD4 as well as tensin homolog (deleted on chromosome 10) and phosphatase, two other proapoptotic target effectors of miR-21, it also resulted in signifi cant down-regulation of phosphorylated protein kinase B and ultimately increased TECs apoptosis (Jia et al., 2013) . Moreover, in response to Ras signaling, AP-1, a transcription factor that induces miR-21 expression, was shown to inhibit PDCD4, leading to a decrease in interleukin (IL)-6 and NF-κB induced apoptosis (Talotta et al., 2009; Sheedy et al., 2010) . In addition to stimulating apoptosis, NF-κB is also known to induce the expression of miR-21 (Sheedy et al., 2010) . However, more is to be learned about the specifi c mechanisms mediating the overall induction of miR-21 and the role of miR-21 as a negative regulator in the apoptosis of TECs involved in AKI.
MiR-21 AND INFLAMMATION
IRI-induced AKI is tightly associated with a robust tubulointerstitial infl ammation response to hypoxia and the process of reperfusion (Bonventre and Zuk, 2004) , both of which not only immediately induce endothelial and tubular cell damage in the initial phase and persistent vasoconstriction in the early phase of AKI, but also subsequently recruit leukocytes leading to the apoptosis and necrosis of endothelial cells and TECs (Rana et al., 2001) . The process of renal TEC apoptosis further constitutes a pro-inflammatory stimulu s along with a variety of soluble mediators that activate and recruit leukocytes, thereby contributing substantially to the cascade effect (Daemen et al., 1999) . A number of potent mediators produced by the injured TECs have been identified as contributors to inflammation,
MicroRNA AND ITS TARGET MOLECULES
MiRNAs are a class of noncoding RNA duplex molecules that are approximately 21-23 nucleotides in length, which regulate the stability or the translational efficiency of target mRNAs (Zamore and Haley, 2005) . MiRNAs are formed through primary transcription in the nucleus by means of RNA polymerase, also referred to as long primary transcripts (pre-miRNAs), processed into 70-to 100-nucleotide sequences by RNase III Drosha, and then exported into the cytoplasm where they are further processed to generate mature miRNA species of the form of double stranded RNAs (Vasudevan et al., 2007) . MiRNAs have been shown to target a number of genes by either enhancing or inhibiting their expression via binding to the 3'-untranslated region (3'UTR) of their target genes. Within a given cell type, both cell-specifi c and diverse miRNAs can target several mRNAs. As a result, miRNAs exert control over several vital processes of cellular activity and homeostasis including cell growth, proliferation, differentiation, and apoptosis.
MiR-21
The amount of understanding surrounding the biological functions of many miRNAs including miR-21 has burgeoned in the past decades (Friedman and Jones, 2009; Krichevsky and Gabriely, 2009 ). However, unlike many other miRNAs, miR-21 is ubiquitously expressed in mammal organ systems such as the heart, spleen, small intestine, and the kidney (Lagos- Quintana et al., 2002) . The location of the human miR-21 gene is identified on chromosome 17q23.2, where it overlaps with the protein-coding gene VMP1, also known as TMEM49. In more recent years, there have been many conserved enhancer elements found to positively regulate miR-21 transcription, including binding sites for activation protein 1 (AP-1), which is composed of Fos and Jun family proteins, Ets/PU.1, C/EBPα, NFI, SRF, p53, and STAT3 (Kumarswamy et al., 2011) . In addition, several transcriptional suppressors have also been reported, including NFI, C/EBPα, Gf1, and estrogen receptor (Fujita et al., 2008; Velu et al., 2009 ). MiR-21 expression is also regulated at the post-transcriptional level by signal transducers such as TGFβ, BMP4, and SMADs (Kumarswamy et al., 2011) . As such, the controlled or down-regulated expression of miR-21 is tightly associated with several fundamental biological and pathological processes. Accumulating evidence also shows miR-21 plays a vital role in stress response, inflammation, apoptosis, and IRI. Additionally, up-regulation of miR-21 expression has been found to be correlated with multiple kidney diseases such as fi brosis, diabetic nephropathy, renal cell carcinoma (RCC), and AKI Chung et al., 2013; Zhong et al., 2013a) . Although most of the regulatory effects of miR-21 on AKI are still not clear, it is reasonable to predict that many novel functions of miR-21 in this fi eld will be uncovered in the near future.
MiR-21 AND APOPTOSIS
Considering tubular epithelial cells (TECs) are damaged as Protein Cell & 2011). Consequently, AKI can result in proliferation of fibroblasts and excessive deposition of extracellular matrix (Yang et al., 2011; Du et al., 2013b) . MiR-21 expression was found to positively correlate with the urine albumin creatine ratio (ACR), tissue inhibitors of metalloproteinase-1 (TIMP1), collagen IV (ColIV), and fi bronectin (FN), which exacerbate tissue fi brosis; while negatively correlating with the creatine clearance ratio (Ccr) and matrix metalloproteinases-9 (MMP-9) protein, which mitigate the fibrosis process by degrading extracellular matrix components in diabetic nephropathy . Furthermore, much evidence shows miR-21 regulates the process of renal injury that leads to fi brosis through several signaling pathways. In one study, MiR-21 was found to be signifi cantly increased via the mammalian target of rapamycin (mTOR)-inhibition, which promotes the processing of the miR-21 transcript (pri-miR-21) into a premature form (pre-miR-21) (Trindade et al., 2013) . Meanwhile, miR-21 Sponge, which quenches endogenous miR-21 levels, attenuated phosphorylation of endogenous inhibitors of mTORC1 by inhibiting TGFβ-stimulated phosphorylation of Akt kinase (Dey et al., 2012) . Another study conducted in vivo identifi ed that miR-21 targeting of Smad7 was involved in TGF-β and NF-κB signaling pathways. Overexpression of miR-21 in kidney cells was shown to enhance the production of fi brotic and infl ammatory markers, while knockdown of miR-21 produced opposite results . Likewise, a strong up-regulation of miR-21 was observed in the kidneys of mice suffering from unilateral ureteral obstruction where primary kidney fi broblasts were induced upon TGFβ. Such results indicate that ectopic expression of miR-21 in primary kidney fi broblasts is suffi cient to promote myofi broblast differentiation (Glowacki et al., 2013) . These findings imply that miR-21 plays a complicated role in the regulation of the fi brotic repair process after AKI.
MiR-21 AND ISCHEMIA REPERFUSION INJURY
Clinical studies have shown that renal IRI is a major cause of AKI (Lameire and Vanholder, 2001; Lameire et al., 2006) . Ischemia markedly initiates injury of both the renal tubular epithelium and renal microvasculature, which is exacerbated upon reperfusion by an increase in oxidative stress, infl ammation, apoptosis, and necrosis (Bonventre and Weinberg, 2003; Devarajan, 2006) . MiR-21 down-regulated apoptosis and necrosis of renal TECs, which promoted cellular proliferation and played a protective role in the response to stress and infl ammation in renal IRI (Lindsay, 2008; Thum et al., 2008a; Godwin et al., 2010) . As shown in a previous animal study, knockdown of miR-21 increased cell death. However, a confl icting result was also noted in vitro: over-expression of miR-21 did not prevent cell death following simulated ischemia (Godwin et al., 2010) . These results indicated the role of miR-21 is a two sided sword in renal IRI: neither under-nor over-expression led to adverse consequences (Fig. 1) . Under-expression of miR-21 results in the increase of cell death since miR-21 acts as an anti-apoptosis agent. In contrast, miR-21 over-expression can including pro-infl ammatory cytokines such as IL-6, IL-1β, IL-8, tumor necrosis factor (TNF), monocyte chemotactic protein-1 (MCP-1), and transforming growth factor-β1 (TGF-β1) (Akcay et al., 2009 ). In addition, the extensive infl ammation found in renal tissue in response to AKI was initially recognized from Toll-like receptors (TLRs), which activate effector cells via several kinases and NF-κB, while also excreting pro-infl ammatory cytokines (Jang and Rabb, 2009 ). It was found that type I interferon (IFN) signaling downstream of TLR2/TLR4 activation likewise played a key role in the mechanism of I/R-triggered kidney damage (Freitas et al., 2011) . Additionally, miR-21 has been found to be highly up-regulated in rat kidneys following tubular injury induced by IRI.
However, in addition to promoting proliferative responses via up-regulation of the survival factor Bcl-2 and down-regulation of the tumor suppressor PDCD4 (Godwin et al., 2010) , miR-21 is thought to be involved in inflammation regulation via other signaling pathways. Recent studies suggest that the amount of macrophage infiltration into diabetic kidneys was markedly reduced after treatment with miR-21 plasmids. Similarly, suppression of miR-21 caused a reduction in the pro-inflammatory cytokine TNF-α and MCP-1 (Zhong et al., 2013a) . In addition, during a novel study involving the hepatitis C virus (HCV), researchers observed HCV-mediated activation of miR-21 expression (Chen et al., 2013) . Such fi ndings demonstrate that the over-expression of miR-21 targeting MyD88 and IRAK1 results in the activation of certain TLRs that trigger MAPK and NF-κB signaling to produce pro-infl ammatory cytokines (Dobrovolskaia et al., 2003; Takeda et al., 2003; Hao et al., 2013) . MyD88 consists of a Toll/IL-1 receptor (TIR) domain that mediates TLR signaling, and a death domain (DD) that mediates downstream IL-1 receptor-associated kinase (IRAK)-4 via DD-DD interaction to form MyD88-IRAK-4 complex which recruits IRAK-1 and IRAK-2, thereby bringing their kinase-like domains close together, which results in phosphorylation of IRAKs and their subsequent activation. Phosphorylated IRAK-1 or IRAK-2 leaves the complex and interacts with the tumor necrosis factor receptor associated factor 6 (TRAF6). Then the complex signaling cascades of phosphorylation and ubiquitination events are initiated, which lead to phosphorylation of IKKα and MAP kinases, and activation of transcription factors including NF-κB, IRFs, and AP-1 family members and production of infl ammatory cytokines (O'Neill and Bowie, 2007; Kawagoe et al., 2008; Carpenter and O'Neill, 2009; Jenkins and Mansell, 2010; Lin et al., 2010) .
MiR-21 AND FIBROSIS
Following severe AKI, the proximal tubule cellular repair process can lead to fi brosis due to cell cycle arrest at the G 2 /M phase. The disturbed balance between hepatocyte growth factor (HGF) and TGF-β1 during the initial stage of AKI, due to increased synthesis of native and foreign HGF in damaged TECs, leads to the generation o f pro-fi brotic factors including cytokines, growth factors, and matrix proteins (Yang et al., 
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& from specific tissue into body fluids during the onset of certain negative physiological and pathological conditions in the body (Laterza et al. 2009 ). MiRNAs were found to be differentially regulated following IRI, which led to problems such as apoptosis (Ren et al. 2009 ), fibrosis (Thum et al. 2008) , epithelial mesenchymal transition (Gregory et al. 2008) , and TLR signaling (Taganov et al. 2006) . Expression of miR-21 was found to be robustly up-regulated following ischemia in TECs (Saikumar et al. 2012) . Furthermore, miR-21 may play a role in fine-tuning the cellular responses to injury in the kidney (Godwin et al. 2010) . Another recent study estimated that the levels of urinary and plasma miR-21 were related to severe AKI and other complications following cardiac surgery. In addition, the predictive power of miR-21 for the progression of AKI was comparable to previously reported biomarkers such as the creatinine ratio, urine neutrophil gelatinase-associated lipocalin (NGAL), urine IL-18, and plasma NGAL (Koyner et al. 2012; Du et al. 2013) . With methodological advances, artificial modifi cation of miR-21 is very likely to be employed not only in the early diagnosis but also in the prevention and treatment of AKI in the near future.
CONCLUSIONS
AKI is a pathological condition characterized by epithelial apoptosis, recruit of leukocytes, and activation of proinflammatory cytokines at the early stage of injury, secretion of pro-fi brotic factors, proliferation of fi broblasts, and excessive deposition of extracellular matrix at the terminal stage of injury. MiR-21 is a activate several signaling pathways leading to inflammation and fi brosis. Therefore, there should be a precise dynamic adjustment mechanism in physiological condition. After suffering ischemia assault, the balance will be destroyed. Expression of miR-21 may be down-regulated in the initial stage of IRI, and up-regulated as a self-defense response and thereby performing an anti-apoptosis effect in spite of the massive death of TECs in the subsequent stage. However, over-expression in the end stage leads to the production of pro-infl ammatory and pro-fi brotic factors. Another recent study supported this showing that 15-min renal IPC signifi cantly increased the expression of miR-21 by 4 h and substantially attenuated ischemia-reperfusion injury that was induced 4 days later. On the other hand, knockdown of miR-21 resulted in signifi cant up-regulation of PCDP4 and a substantial increase in tubular cell apoptosis. The same study also showed that miR-21 performed a renal protective effect by further delaying IPC against subsequent renal IRI (Xu et al. 2012) . Therefore, up-regulation of miR-21 during a short period of ischemia followed by reperfusion can activate endogenous defense mechanisms that protect against a subsequent, sustained ischemic insult; however, imbalanced expression may contribute to a serious irreversible outcome.
MiR-21 AS A DIAGNOSTIC BIOMARKER AND THERAPEUTIC TARGE T
MiRNAs are rapidly emerging as early diagnostic biomarkers in human diseases due to the noted release of miRNAs On one hand, in the initial stage of AKI, miR-21 up-regulation switches on a defense mechanism against the stimulation of apoptosis recognized by TLRs, which down-regulates PDCD4 by directly targeting the 3′UTR, as well as up-regulates survival factor Bcl-2, which acts as a strong anti-apoptotic factor to inhibit cell death. Meanwhile, inhibition of PDCD4 leads to a decrease in NF-κB induced apoptosis. However, on the other hand, in the end stage of AKI, over-expression of miR-21 targeting MyD88 and IRAK1 results in the continuous activation of certain TLRs to amplify cascades of phosphorylation and ubiquitination events to trigger NF-κB to produce proinfl ammatory cytokines. Moreover, excessive up-regulation of miR-21 positively correlates with TIMP1, ColIV, and FN, while negatively correlating with MMP-9, which exacerbates tissue fi brosis by intensifying cell death and tissue injury. 
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typical miRNA that functions as a regulator involved in several fundamental biological and pathologic processes. Previous studies confi rmed the extensive involvement of miR-21 i n apoptosis and both inflammatory and fi brotic signaling pathways; however, it was found that miR-21 might play an opposite role in AKI. On one hand, up-regulation of miR-21 acts as a defense mechanism to decrease cell death. On the other hand, over-expression of miR-21, stimulated by massive cell death, results in severe inflammation and fibrosis. Therefore, there should be a precise dynamic adjustment to miR-21 in physiological condition. In addition, miR-21 is identifi ed as a novel biomarker for early diagnosis and a potential therapeutic target in preventing and treating AKI. However, the mechanisms mediating the induction of miR-21 following AKI have not been experimentally validated. Furthermore, it should also be noted that large-scale studies are required to evaluate the clinical values of miR-21 as predictive markers in AKI.
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